Complete CAMP Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
CAMP DCF Analysis
CAMP (CAMP4 Therapeutics Corporation) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
---|---|---|---|---|---|---|---|---|
Revenue | $295.8M | $294.9M | $186.2M | $167.6M | $150.8M | $135.8M | $122.2M | $110.0M |
Revenue Growth % | - | -0.3% | -36.9% | -10.0% | -10.0% | -10.0% | -10.0% | -10.0% |
EBIT | $-15.3M | $-21.5M | $-8.7M | $8.4M | $7.5M | $6.8M | $6.1M | $5.5M |
EBIT Margin % | -5.2% | -7.3% | -4.7% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
NOPAT | $-11.5M | $-16.1M | $-6.5M | $6.3M | $5.7M | $5.1M | $4.6M | $4.1M |
NOPAT Margin % | -3.9% | -5.5% | -3.5% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
Capex | $11.4M | $13.3M | $11.1M | $8.3M | $7.1M | $6.1M | $5.2M | $4.4M |
Capex / Revenue % | 3.8% | 4.5% | 6.0% | 5.0% | 4.7% | 4.5% | 4.2% | 4.0% |
Depreciation | $22.0M | $22.8M | $21.8M | $15.0M | $13.5M | $12.2M | $10.9M | $9.8M |
D&A / Revenue % | 7.4% | 7.7% | 11.7% | 9.0% | 9.0% | 9.0% | 9.0% | 9.0% |
Change in NWC | $-9.3M | $-16.1M | $-22.6M | $-4.8M | $-3.5M | $-2.5M | $-1.8M | $-1.3M |
NWC Change / Revenue % | -3.2% | -5.5% | -12.2% | -2.9% | -2.3% | -1.8% | -1.5% | -1.2% |
Unlevered FCF | $8.5M | $9.5M | $26.8M | $17.8M | $15.5M | $13.7M | $12.1M | $10.8M |
UFCF % Chg. | - | 11.8% | 181.3% | -33.5% | -12.8% | -12.0% | -11.3% | -10.7% |
FCF / Revenue % | 2.9% | 3.2% | 14.4% | 10.6% | 10.3% | 10.1% | 9.9% | 9.8% |
Discount Factor | - | - | - | 0.955 | 0.912 | 0.871 | 0.832 | 0.795 |
Present Value of FCF | - | - | - | $17.0M | $14.2M | $11.9M | $10.1M | $8.6M |
Sum of PV of UFCF | - | - | - | $17.0M | $31.2M | $43.1M | $53.2M | $61.8M |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
WACC Calculation | Value |
---|---|
Cost of Debt | 6.9% |
Tax Rate | 25.0% |
After Tax Cost of Debt | 5.2% |
Risk Free Rate | 4.40% |
Market Risk Premium | 4.3% |
Beta | -0.61 |
Cost of Equity | 1.8% |
Total Debt | $240.4M |
Market Cap | $38.7M |
Total Capital | $279.1M |
Debt Weighting | 86.1% |
Equity Weighting | 13.9% |
WACC | 4.7% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
Terminal Value Calculation | Value |
---|---|
Terminal Growth Rate | 2.5% |
Final Year FCF | $10.8M |
Terminal Value | $504.0M |
PV of Terminal Value | $400.5M |
Cumulative PV of UFCF | $61.8M |
Net Debt | $198.5M |
Equity Value | $263.8M |
Shares Outstanding | 37.0M |
Implied Share Price | $7 |
Current Share Price | $2 |
Implied Upside/(Downside) | +271.1% |
Valuation Summary
$7.12
Implied Price
$1.92
Current Price
+271.1%
Upside/Downside
4.7%
WACC
CAMP Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 7 peer companies in Healthcare
P/E Ratio
$-1.39
-172.3%
Peer Median: 0.5x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$18.78
+878.3%
Peer Median: 1.4x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for CAMP's business model and current situation.
Multiple Comparison
Multiple | CAMP Current | Peer Median | Peer Average | Premium/Discount | Assessment |
---|---|---|---|---|---|
P/E Ratio | -0.7x | 0.5x | 0.5x | -238.3% | Undervalued |
EV/EBITDA | 57.8x | 0.0x | 0.0x | Infinity% | Overvalued |
P/S Ratio | 0.1x | 1.4x | 1.9x | -89.8% | Undervalued |
Peer Companies
Click any company to view their valuation
Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
---|---|---|---|---|
$0.05B | 0.0x | 0.0x | 1.4x | |
$0.05B | 0.0x | 0.0x | 0.0x | |
$0.05B | 0.0x | 0.0x | 5.8x | |
$0.04B | 0.0x | 57.8x | 0.1x | |
$0.06B | 0.0x | 0.0x | 0.0x | |
$0.04B | 0.0x | 0.0x | 0.3x | |
$0.05B | 0.5x | 0.0x | 103.1x |